These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14600575)

  • 1. Increases in CD4+ T lymphocytes occur without increases in thymic size in HIV-infected subjects receiving interleukin-2 therapy.
    Lu AC; Jones EC; Chow C; Miller KD; Herpin B; Rock-Kress D; Metcalf JA; Lane HC; Kovacs JA
    J Acquir Immune Defic Syndr; 2003 Nov; 34(3):299-303. PubMed ID: 14600575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymic function in HIV-infection.
    Kolte L
    Dan Med J; 2013 Apr; 60(4):B4622. PubMed ID: 23651726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-2 therapy and thymic production of naive CD4 T cells in HIV-infected patients with severe CD4 lymphopenia.
    Carcelain G; Saint-Mézard P; Altes HK; Tubiana R; Grenot P; Rabian C; de Boer R; Costagliola D; Katlama C; Debré P; Autran B
    AIDS; 2003 Apr; 17(6):841-50. PubMed ID: 12660531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased peripheral expansion of naive CD4+ T cells in vivo after IL-2 treatment of patients with HIV infection.
    Natarajan V; Lempicki RA; Sereti I; Badralmaa Y; Adelsberger JW; Metcalf JA; Prieto DA; Stevens R; Baseler MW; Kovacs JA; Lane HC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10712-7. PubMed ID: 12149467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved thymopoietic potential in aviremic HIV infected individuals treated with HAART by intermittent IL-2 administration.
    Porcellini S; Vallanti G; Nozza S; Poli G; Lazzarin A; Tambussi G; Siccardi AG; Grassi F
    AIDS; 2003 Jul; 17(11):1621-30. PubMed ID: 12853744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between larger thymic size and higher thymic output in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.
    Kolte L; Dreves AM; Ersbøll AK; Strandberg C; Jeppesen DL; Nielsen JO; Ryder LP; Nielsen SD
    J Infect Dis; 2002 Jun; 185(11):1578-85. PubMed ID: 12023763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparameter evaluation of human thymic function: interpretations and caveats.
    Harris JM; Hazenberg MD; Poulin JF; Higuera-Alhino D; Schmidt D; Gotway M; McCune JM
    Clin Immunol; 2005 May; 115(2):138-46. PubMed ID: 15885636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous IL-7 is associated with increased thymic volume in adult HIV-infected patients under highly active antiretroviral therapy.
    Ruiz-Mateos E; de la Rosa R; Franco JM; Martinez-Moya M; Rubio A; Soriano N; Sanchez-Quijano A; Lissen E; Leal M
    AIDS; 2003 May; 17(7):947-54. PubMed ID: 12700443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of thymic function-related markers to predict early CD4 T-cell repopulation in adult HIV-infected patients on HAART.
    Ruiz-Mateos E; de la Rosa R; Soriano N; Martinez-Moya M; Rubio A; Sánchez-Quijano A; Lissen E; Leal M
    Antivir Ther; 2003 Aug; 8(4):289-94. PubMed ID: 14518697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-infected patients with a large thymus maintain higher CD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy.
    Kolte L; Ryder LP; Albrecht-Beste E; Jensen FK; Nielsen SD
    Scand J Immunol; 2009 Dec; 70(6):608-13. PubMed ID: 19906203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymic volume is associated independently with the magnitude of short- and long-term repopulation of CD4+ T cells in HIV-infected adults after highly active antiretroviral therapy (HAART).
    Ruiz-Mateos E; Rubio A; Vallejo A; De la Rosa R; Sanchez-Quijano A; Lissen E; Leal M
    Clin Exp Immunol; 2004 Jun; 136(3):501-6. PubMed ID: 15147352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune).
    Pido-Lopez J; Burton C; Hardy G; Pires A; Sullivan A; Gazzard B; Aspinall R; Gotch F; Imami N
    AIDS Res Hum Retroviruses; 2003 Feb; 19(2):103-9. PubMed ID: 12639245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients.
    Keh CE; Shen JM; Hahn B; Hallahan CW; Rehm CA; Thaker V; Wynne SM; Davey RT; Lane HC; Sereti I
    AIDS; 2006 Feb; 20(3):361-9. PubMed ID: 16439869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymic volume, T-cell populations, and parameters of thymopoiesis in adolescent and adult survivors of HIV infection acquired in infancy.
    Lee JC; Boechat MI; Belzer M; Church JA; De Ville J; Nielsen K; Weston S; Geng Y; Dunaway T; Kitchen C; Krogstad PA
    AIDS; 2006 Mar; 20(5):667-74. PubMed ID: 16514296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymic Function Impacts the Peripheral CD4/CD8 Ratio of HIV-Infected Subjects.
    Rosado-Sánchez I; Herrero-Fernández I; Genebat M; Ruiz-Mateos E; Leal M; Pacheco YM
    Clin Infect Dis; 2017 Jan; 64(2):152-158. PubMed ID: 27986677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological recovery failure in cART-treated HIV-positive patients is associated with reduced thymic output and RTE CD4+ T cell death by pyroptosis.
    Carvalho-Silva WHV; Andrade-Santos JL; Souto FO; Coelho AVC; Crovella S; Guimarães RL
    J Leukoc Biol; 2020 Jan; 107(1):85-94. PubMed ID: 31691351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of thymic reconstitution after highly active antiretroviral therapy in HIV-1 infection.
    Hardy G; Worrell S; Hayes P; Barnett CM; Glass D; Pido-Lopez J; Imami N; Aspinall R; Dutton J; Gazzard B; Peters AM; Gotch FM
    HIV Med; 2004 Mar; 5(2):67-73. PubMed ID: 15012644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells.
    Sereti I; Martinez-Wilson H; Metcalf JA; Baseler MW; Hallahan CW; Hahn B; Hengel RL; Davey RT; Kovacs JA; Lane HC
    Blood; 2002 Sep; 100(6):2159-67. PubMed ID: 12200381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy.
    Smith KY; Valdez H; Landay A; Spritzler J; Kessler HA; Connick E; Kuritzkes D; Gross B; Francis I; McCune JM; Lederman MM
    J Infect Dis; 2000 Jan; 181(1):141-7. PubMed ID: 10608760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymic Function as a Predictor of Immune Recovery in Chronically HIV-Infected Patients Initiating Antiretroviral Therapy.
    Rb-Silva R; Nobrega C; Azevedo C; Athayde E; Canto-Gomes J; Ferreira I; Cheynier R; Yates AJ; Horta A; Correia-Neves M
    Front Immunol; 2019; 10():25. PubMed ID: 30804925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.